[ad_1]
The International Iberian Nanotechnology Laboratory (INL), based in Braga, is leading a European project of 6.1 million euros that aims to support the commercialization of new products that fight the new coronavirus, it was announced today.
In a statement, INL states that the consortium of 11 partners will support up to 30 projects that test and validate applications in various areas, from medical technologies, environmental monitoring systems, sensors, protection of health workers, artificial intelligence and data mining.
In this sense, the project, called INNO4COV-19, will invest half of the available budget in direct support to some 30 selected companies, through an open call that is developed in three different phases during the first year of the project.
Quoted in the statement, Mariana Fernandes, coordinator of INNO4COV-19, says that she believes that the initiative will be a “fundamental tool” to promote the emergence of strategies and technologies to combat covid-19 in the short and medium term.
“Our goal is also to find and support new solutions that better prepare Europe and its citizens for possible pandemics that we may have to face in the future,” he said.
Each selected project will receive support of up to 100,000 euros, also benefiting from the technical, legal and business support of the entire consortium.
The call opens today and the first phase of applications will conclude on November 30.
The covid-19 pandemic has already claimed almost 1.2 million deaths and more than 46 million cases of infection worldwide, according to a report by the French agency AFP.
In Portugal, 2,544 people died from 144,341 confirmed cases of infection, according to the most recent bulletin from the Directorate General of Health.
The disease is transmitted by a new coronavirus detected in late December 2019 in Wuhan, a city in central China.
[ad_2]
